Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity
Ribas, A. et al. SD-101 in combination with pembrolizumab in advanced melanoma: results of a phase Ib, multicenter study. Cancer Discov. 8, 1250–1257 (2018).…
من لبنان لكل لبنان
